H.R. 4313: Hospital Inpatient Services Modernization Act

The House passed H.R. 4313, the Hospital Inpatient Services Modernization Act, by unanimous voice vote, a quiet decision with a big reach. The bill takes Medicare's pandemic-era hospital-at-home waiver, set to expire January 30, 2026, and pushes it out to September 30, 2030.

Hospital-at-home pays health systems to treat acute patients (pneumonia, heart failure, serious infections) in their own homes instead of an inpatient ward. Patients get around-the-clock remote monitoring plus in-person nursing visits, and Medicare covers it as if it were a hospital stay. More than 300 hospitals across 34-plus states have used the waiver since it launched in November 2020.

The bill also orders a second, deeper study. CMS already ran an initial review that found lower mortality and fewer hospital-acquired conditions for hospital-at-home patients than for comparable inpatients. The follow-up, due September 30, 2028, has to dig into the harder questions: how hospitals decide who is safe to send home, how often patients get bounced back to the hospital, and whether home care costs Medicare more or less than a traditional bed.

It also has to look at who is being offered the option. The study must break patients down by race, ethnicity, income, housing, distance from the hospital, and whether they are covered by both Medicare and Medicaid, then control for selection bias, the tendency to enroll the healthiest, best-supported patients and make the numbers look rosier than they are.

The five-year length is the tell. A two- or three-year extension reads as a bridge; five years reads as a decision to make hospital-at-home a permanent fixture of Medicare. Supporters, a bipartisan group led by Rep. Vern Buchanan, say health systems need that runway to keep investing in monitoring tech and home-nursing teams. Skeptics note that most of the favorable evidence so far comes from well-resourced systems treating carefully chosen patients, not the average beneficiary in a rural county.

The price tag is small and self-funded. The bill puts $2.5 million toward the new study and pays for it by trimming the same $2.5 million from a separate Medicare reserve account, so it doesn't add to the deficit. The bigger fiscal question, whether treating patients at home actually saves Medicare money or just moves where the bills come from, is exactly what the 2028 study is supposed to answer.